Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury

This publication has 30 references indexed in Scilit:

• Differential Response of Primary Alveolar Type I and Type II Cells to LPS Stimulation
  PLOS ONE, 2013
• Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
  PLOS ONE, 2011
• Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
• Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment
  Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
• The Great Big Alveolar TI Cell: Evolving Concepts and Paradigms
  Cellular Physiology and Biochemistry, 2010
• RAGE expression and NF‐κB activation attenuated by extracellular domain of RAGE in human salivary gland cell line
  Journal of Cellular Physiology, 2009
• A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
  The American Journal of Pathology, 2008
• The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair
  European Respiratory Journal, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• The Acute Respiratory Distress Syndrome
  New England Journal of Medicine, 2000